Table of Contents

company-logo

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.

Evaxion Biotech Dividend Announcement

• Evaxion Biotech does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Evaxion Biotech dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Evaxion Biotech Dividend History

Evaxion Biotech Dividend Yield

Evaxion Biotech current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Evaxion Biotech stock? Use our calculator to estimate your expected dividend yield:

Evaxion Biotech Financial Ratios

P/E ratio-0.73
PEG ratio-0.01
P/B ratio112.75
ROE5765.59%
Payout ratio0.00%
Current ratio0.00
Quick ratio0.00
Cash Ratio0.00

Evaxion Biotech Dividend FAQ

Does Evaxion Biotech stock pay dividends?
Evaxion Biotech does not currently pay dividends to its shareholders.
Has Evaxion Biotech ever paid a dividend?
No, Evaxion Biotech has no a history of paying dividends to its shareholders. Evaxion Biotech is not known for its dividend payments.
Why doesn't Evaxion Biotech pay dividends?
There are several potential reasons why Evaxion Biotech would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Evaxion Biotech ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Evaxion Biotech has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Evaxion Biotech a dividend aristocrat?
Evaxion Biotech is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Evaxion Biotech a dividend king?
Evaxion Biotech is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Evaxion Biotech a dividend stock?
No, Evaxion Biotech is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Evaxion Biotech stocks?
To buy Evaxion Biotech you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Evaxion Biotech stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.